Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Go back to Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation| (NASDAQ: TVGN) | Delayed: 5.94 +0.17 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.77 | 52 Week High | $ | |||
| Open | $5.95 | 52 Week Low | $ | |||
| Day High | $6.01 | P/E | N/A | |||
| Day Low | $5.87 | EPS | $ | |||
| Volume | 2,072 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 7,561 | |||||
